Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Familial Mediterranean Fever »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
False Negative Reactions < Familial Mediterranean Fever < Family Health  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000227 (2020) Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi KawakamiAn open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.
000567 (2019) Erika Aikawa [Japon] ; Toshimasa Shimizu [Japon] ; Tomohiro Koga [Japon] ; Yushiro Endo [Japon] ; Masataka Umeda [Japon] ; Tomoko Hori [Japon] ; Junji Irie [Japon] ; Kishio Kuroda [Japon] ; Mizuna Eguchi [Japon] ; Momoko Okamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Remi Sumiyoshi [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Atsushi Kawakami [Japon]Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.
000881 (2018) Tomohiro Koga [Japon] ; Shuntaro Sato [Japon] ; Junya Miyamoto [Japon] ; Naoko Hagimori [Japon] ; Yurika Kawazoe [Japon] ; Kumiko Arinaga [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami [Japon]Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
000A01 (2017) Masataka Umeda [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Kaoru Terada [Japon] ; Gou Takeo [Japon] ; Nobuhisa Yonemitsu [Japon] ; Yukitaka Ueki [Japon] ; Kiyoshi Migita [Japon] ; Atsushi Kawakami [Japon]Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
000A03 (2017) Serdal Ugurlu [Turquie] ; Aysa Hacioglu [Turquie] ; Yasaman Adibnia [Turquie] ; Vedat Hamuryudan [Turquie] ; Huri Ozdogan [Turquie]Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
000D33 (2016) Satoshi Hamanoue [Japon] ; Tatsuya Suwabe [Japon] ; Junichi Hoshino [Japon] ; Keiichi Sumida [Japon] ; Koki Mise [Japon] ; Noriko Hayami [Japon] ; Naoki Sawa [Japon] ; Kenmei Takaichi [Japon] ; Takeshi Fujii [Japon] ; Kenichi Ohashi [Japon] ; Masahide Yazaki [Japon] ; Shuichi Ikeda [Japon] ; Yoshifumi Ubara [Japon]Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
000F05 (2016) P. Portincasa [Italie]Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare.
000F20 (2016) Tomohiro Koga ; Kiyoshi Migita ; Atsushi KawakamiBiologic therapy in familial Mediterranean fever.
000F83 (2015) Sedat Yilmaz [Turquie] ; Muhammet Cinar [Turquie] ; Ismail Simsek [Turquie] ; Hakan Erdem [Turquie] ; Salih Pay [Turquie]Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.
001859 (2011) Prashantha M. Vaitla [Royaume-Uni] ; Paul M. Radford ; Patrick J. Tighe ; Richard J. Powell ; Elizabeth M. Mcdermott ; Ian Todd ; Elizabeth DreweRole of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
001D10 (????) Kevser Gök ; Gizem Cengiz ; Kemal Erol ; Salih OzgocmenTofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever.
001D40 (????) John Serelis [Grèce] ; Sophia Christaki [Grèce] ; Fotini N. Skopouli [Grèce]Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
001D77 (????) Keita Fujikawa [Japon] ; Kiyoshi Migita ; Toshiaki Tsukada ; Masataka Umeda ; Fumiaki Nonaka ; Atsushi Kawakami ; Katsumi EguchiInterleukin-6 targeting therapy in familial Mediterranean fever.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Familial Mediterranean Fever" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Familial Mediterranean Fever" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Familial Mediterranean Fever
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021